Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with immune thrombocytopenia

Creative Commons License

AYDIN K., Gurkan E.

CUKUROVA MEDICAL JOURNAL, cilt.47, sa.2, ss.715-721, 2022 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.17826/cumj.1085840
  • Dergi Adı: CUKUROVA MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Academic Search Premier, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.715-721
  • Anahtar Kelimeler: Immune thrombocytopenia, intravenous immunoglobulin, methylprednisolone, conventional prednisolone, treatment, INTERNATIONAL CONSENSUS REPORT, PURPURA, DEXAMETHASONE, EPIDEMIOLOGY, MANAGEMENT, CHILDREN
  • Çukurova Üniversitesi Adresli: Hayır

Özet

Purpose: We aimed to compare the efficacy of high-dose methylprednisolone (HDP) with intravenous immunoglobulin (IVIG) and conventional prednisolone (CDP) as a first-line therapy in adult patients with immune thrombocytopenia (ITP).